Literature DB >> 786079

Mutagenicity of volatile anesthetics: halothane.

J M Baden, M Brinkenhoff, R S Wharton, B A Hitt, V F Simmon, R I Mazze.   

Abstract

The mutagenicity of halothane was tested in an in-vitro microbial assay system employing two histidine-dependent mutants of Salmonella typhimurium, TA98 and TA100, Halothane in concentrations ranging from 0.1 to 30 per cent was incubated with bacteria in the presence or absence of a metabolic activation system prepared from either rat liver treated with Aroclor 1254 or human liver. Trifluoroacetic acid, a major metabolite of halothane, and urine from patients anesthetized with halothane also were tested. Halothane, trifluoroacetic acid, and patients' urines were not mutagenic.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786079     DOI: 10.1097/00000542-197609000-00011

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  Occupational exposure to volatile anaesthetics: epidemiology and approaches to reducing the problem.

Authors:  C Byhahn; H J Wilke; K Westpphal
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Chromosome and sister-chromatid exchange analysis in peripheral lymphocytes, and mutagenicity of urine in anesthesiology personnel.

Authors:  J Karelová; A Jablonická; J Gavora; L Hano
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

Review 3.  The Salmonella mutagenicity assay: the stethoscope of genetic toxicology for the 21st century.

Authors:  Larry D Claxton; Gisela de A Umbuzeiro; David M DeMarini
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

4.  Detection of mutagenic activity in the urines of anesthesiologists: a preliminary report.

Authors:  E C McCoy; R Hankel; H S Rosenkranz; J G Giuffrida; D V Bizzari
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

5.  Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane.

Authors:  A J Garro; R A Phillips
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

6.  Bioactivation and covalent binding of halothane to liver macromolecules.

Authors:  I G Sipes; T L Podolsky; B R Brown
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.